Efficacy of Ipomea Pes-caprae Ointment as an add-on Therapy in Patient With Jellyfish Dermatitis

Jellyfish Dermatitis Clinical Trial

Official title:

Efficacy of Ipomea Pes-caprae Ointment as an add-on Therapy in Patient With Jellyfish Dermatitis

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT00944203
• Other study ID #: TMEC09-031
• Status: Completed
• Phase: Phase 2
• First received: July 22, 2009
• Last updated: March 20, 2018
• Start date: July 2009
• Est. completion date: March 2017

Study information

• Verified date: March 2018
• Source: Mahidol University
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

This is an open label, prospective, test of superiority efficacy trial of Ipomea pes-caprae ointment as an add-on therapy in patient with jellyfish dermatitis. Each patient will receive standard medical treatment depend on the severity of the disease. The doctor will divide the dermatitis area of each patient into two parts. Ipomea pes-caprae ointment will be applied as an add-on therapy to the "test area", while the ointment will not be applied to the "control area". Patients will be asked to come for follow up 6 times in the 28-days study period. Primary objective is to compare the healing time of dermatitis in both areas.

Description:

The "Test area" and "Control area" are allocated in each participant. We use the Internal Control fashion. The healing time of each area will be collected as an outcome measure.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 54
• Est. completion date: March 2017
• Est. primary completion date: March 2017
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• clinical diagnosis of jellyfish dermatitis

• total lesion area is more than 4 square centimeter

Exclusion Criteria:

• expose to jellyfish more than 7 days

• severe systemic reaction to jellyfish

• allergy to Ipomea pes-caprae or the component of the ointments

Related Conditions & MeSH terms

• Dermatitis
• Jellyfish Dermatitis
• Jellyfish Venoms

Intervention

Drug:
• Ipomea pes-caprae ointment
Ipomea pes-caprae ointment will be applied twice a day as an add-on therapy.

Locations

Country	Name	City	State
Thailand	Hospital for Tropical Diseases, Faculty of Tropical Medicine, Mahidol University	Bangkok

Sponsors (1)

Lead Sponsor	Collaborator
Mahidol University

Country where clinical trial is conducted

Thailand, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Healing time of the Jellyfish dermatitis lesion (days)		Follow up to 28 days